Skip to main content

  • Exposure to glucocorticoids prior to transcatheter aortic valve replacement is associated with reduced incidence of high-degree AV block and pacemaker

    • Posted: 04/25/2019
    • Author:

      Brett Oestreich, Sergey Gurevich, Selcuk Adabag, Rosemary Kelly, Gregory Helmer, Ganesh Raveendran, Demetris Yannopoulos, Timinder Biring and Santiago Garcia

    • 2019CRM

    Abstract

    Background

    Tissue edema and inflammation, which occur at the device landing zone during valve deployment, may contribute to the pathophysiology of conduction abnormalities after transcatheter aortic valve replacement (TAVR).

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details